PyInvesting

Market research

ARGX.BR argenx SE

Current ticker: ARGX.BR

BR EUR Healthcare

Latest close

858.20 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
56B
P/E ratio
35.58
Analyst target
1009.2252
Dividend yield
Not available
Beta
-0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

argenx SE is currently in a long term uptrend where the price is trading 6.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 300.7.

argenx SE's total revenue sank by 70.8% to $8M since the same quarter in the previous year.

Its net income has dropped by 33.8% to $-158M since the same quarter in the previous year.

Finally, its free cash flow fell by 246.5% to $-136M since the same quarter in the previous year.

Based on the above factors, argenx SE gets an overall score of 2/5.